Early Efficacy of RMP1-14 (ICH1132) Antibody Unveiled
A new study demonstrates that ichorbio's RMP1-14 (ICH1132) antibody shows significant early-stage efficacy and a consistent performance profile in tumor growth inhibition studies against Competitor B.
Key Benefits:
|
||||||||||||||||||||||||||||||||